An interventional study of Medical Music and Narrative Writing in Post-traumatic Stress Disorder and Moral Injury, sponsored by Weill Medical College of Cornell University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-22.
Sponsored by Weill Medical College of Cornell University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 14 studies in Stress Disorders, Post-Traumatic by Weill Medical College of Cornell University — 4 open to participants now, 4 under way, none of them phase 3. Stress Disorders, Post-Traumatic · Weill Medical College of Cornell University.
Among the 14 studies in Stress Disorders, Post-Traumatic by Weill Medical College of Cornell University, this one is the 3rd largest by planned enrollment of the 12 interventional ones that give a count, is the only one that started in 2022, is one of 7 with no phase, and was the 12th registered.
2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.
Browse Stress Disorders, Post-Traumatic studies →4 of the 14 studies in Stress Disorders, Post-Traumatic by Weill Medical College of Cornell University are open now, in 1 country. Recruiting first, the newest first:
Weill Medical College of Cornell University · Sites in United States
Ages 18+
Weill Medical College of Cornell University · Sites in United States
Ages 18+
Weill Medical College of Cornell University · Sites in United States
Ages 18–85
By country, each count listing its studies:
Of the 416 Stress Disorders, Post-Traumatic studies recruiting now, 188 (45%) set no upper age limit and 202 (49%) stop at 75 or younger; 62 take children under 18; 88 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
14 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 1 · Phase 3 1 · Phase 4 1
First in 2003; this study’s year is marked. 1 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 120 is above the median of 69 across 2,203 interventional studies indexed under Stress Disorders, Post-Traumatic.
Median enrollment 23 across the 12 interventional studies, 63 across the 2 observational. Of the 10 that completed or were terminated, 4 (40%) have results posted.
This tab as a report to print or save as PDF → With an account.
Weill Medical College of Cornell University is the lead sponsor of 893 studies on the registry; 165 are open to participants now.
Of its 124 completed or terminated interventional studies of FDA-regulated products, 95 (77%) have results posted.
3 of the studies in Stress Disorders, Post-Traumatic by Weill Medical College of Cornell University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04887116Weill Medical College of Cornell UniversityPiloting Virtual Reality Environments to Treat PTSD in Healthcare Workers | 2027-01 |
| NCT03803332Weill Medical College of Cornell UniversityA Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel | 2027-03 |
| NCT07225049Weill Medical College of Cornell UniversityIntegrated PTSD and Chronic Pain Treatment | 2027-08 |
Add all 3 to your calendar (.ics) → With an account.
Among the 14 studies in Stress Disorders, Post-Traumatic by Weill Medical College of Cornell University, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
It is expected that large numbers of healthcare workers experience a broad range of psychological reactions and symptoms including anxiety, depression, moral distress, and trauma symptoms that will cause both significant suffering as well as occupational and social impairment. The purpose of this study is to find interventions which are helpful in treating psychological distress in healthcare workers adversely affected by occupational-related trauma.
There are two phases of the study. All participants will take part in Phase I, which consists of 4 sessions over a two-week period of either a narrative writing intervention or a medical music intervention. Participants will be randomly assigned to the narrative writing intervention or medical music intervention.
After Phase I, participants will be re-assessed. Healthcare workers who meet criteria for PTSD will be given the option to participate in Phase II of the study, in which they will be offered a choice between one of two evidence-based treatments for PTSD: Interpersonal Therapy (IPT) or Exposure Therapy (ET). Both treatments are comprised of ten 75-minute sessions scheduled twice weekly. Participants will be allowed to choose a preferred treatment in Phase II. After Phase II participants will complete a final assessment concluding the study. All interventions will be offered using distance technology.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
For phase II additional inclusion criteria:
- Current diagnosis of PTSD
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will complete four medical music sessions that are 20 minutes in length each.
Behavioral: Medical Music
Participants will complete four narrative writing sessions that are 20 minutes in length each.
Behavioral: Narrative Writing
IPT is comprised of ten 75-minute sessions scheduled twice weekly.
Behavioral: Interpersonal Psychotherapy
ET is comprised of ten 75-minute sessions scheduled twice weekly.
Behavioral: Prolonged Exposure Therapy
Participants randomized to this condition will complete 4 medical music sessions over the course of 2 weeks
Participants randomized to this condition will complete 4 narrative writing sessions over the course of 2 weeks
Psychotherapy including imaginal exposure for PTSD
Psychotherapy that focuses on the effects of PTSD on current interpersonal functioning
Feasibility Indicator: Recruitment (Phase I)
Feasibility assessment will include recruitment defined as number of individuals interested in the intervention.
Time frame: Baseline
Feasibility Indicator: Recruitment (Phase II)
Feasibility assessment will include: recruitment defined as number of individuals interested in the intervention.
Time frame: Post-Phase I Assessment at week 2
Feasibility Indicator: Enrollment (Phase I)
Feasibility assessment will include enrollment defined as number of participants signing the informed consent form.
Time frame: Baseline
Feasibility Indicator: Enrollment (Phase II)
Feasibility assessment will include enrollment defined as number of individuals beginning phase II.
Time frame: Post-Phase I Assessment at approximately week 2
Feasibility Indicator: Retention (Phase I)
Feasibility assessment will include retention defined as the number of participants completing the full course of Phase I interventions.
Time frame: Post-Phase I Assessment at approximately week 2
Feasibility Indicator: Retention (Phase II)
Feasibility assessment will include retention defined as the number of participants completing the full course of Phase II interventions.
Time frame: Post-Phase II Assessment at approximately week 7
Acceptability Indicator: Satisfaction (Phase I)
Acceptability and treatment satisfaction will be rated with a Likert scale.
Time frame: Post-Phase I Assessment at approximately week 2
Acceptability Indicator: Satisfaction (Phase II)
Acceptability and treatment satisfaction will be rated with a Likert scale.
Time frame: Post-Phase II Assessment at approximately week 7
Preliminary Efficacy as Measured by Change in Clinician-Administered PTSD Scale Score (Phase I)
Change in Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) Score. Total Scores range from 0-80. Higher scores indicate greater symptom severity.
Time frame: Start of Phase I to approximately 2 weeks
Preliminary Efficacy as Measured by Change in Clinician-Administered PTSD Scale Score (Phase II)
Change in Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) Score. Total Scores range from 0-80. Higher scores indicate greater symptom severity.
Time frame: Start of Phase II to approximately 5 weeks
Change in Anxiety Symptoms measured by the Generalized Anxiety Disorder 7-Item Scale (Phase I)
Scored between 0-21: Cut offs: 0-4 = None 5-9 = Mild anxiety 10-14 = Moderate anxiety 15-21 = Severe anxiety Higher scores indicate greater symptom severity.
Time frame: Start of Phase I to approximately 2 weeks
Change in Anxiety Symptoms measured by the Generalized Anxiety Disorder 7-Item Scale (Phase II)
Scored between 0-21: Cut offs: 0-4 = None 5-9 = Mild anxiety 10-14 = Moderate anxiety 15-21 = Severe anxiety Higher scores indicate greater symptom severity.
Time frame: Start of Phase II to approximately 5 weeks
Change in Depressive Symptoms measured by the Quick Inventory of Depressive Symptomology (Phase I)
16-item self-report measure. Scored between 0-3. Higher scores indicate greater symptom severity
Time frame: Start of Phase I to approximately 2 weeks
Change in Depressive Symptoms measured by the Quick Inventory of Depressive Symptomology (Phase II)
16-item self-report measure. Scored between 0-3. Higher scores indicate greater symptom severity.
Time frame: Start of Phase II to approximately 5 weeks
Change in score on the Pittsburgh Sleep Quality Index (PSQI) (Phase I)
24 item self-report measure. 19 questions are evaluated. Each item in the scale is rated between 0 (no distress) and 3 (serious distress). The total PSQI score ranges from 0-21. Sleep quality of the patients with a total score of 5 and below is considered "good". A score of greater than 5 refers to poor sleep quality.
Time frame: Start of Phase I to approximately 2 weeks
Change in score on the Pittsburgh Sleep Quality Index (PSQI) (Phase II)
24 item self-report measure. 19 questions are evaluated. Each item in the scale is rated between 0 (no distress) and 3 (serious distress). The total PSQI score ranges from 0-21. Sleep quality of the patients with a total score of 5 and below is considered "good". A score of greater than 5 refers to poor sleep quality.
Time frame: Start of Phase II to approximately 5 weeks
Change in score on the Moral Injury Symptom Scale: Healthcare Professionals Version (Phase I)
11 item self-report measure measuring one's experiences as a healthcare professional and how they are feeling currently. Scored between 1-10. Higher scores indicate greater moral distress.
Time frame: Start of Phase I to approximately 2 weeks
Change in score on the Moral Injury Symptom Scale: Healthcare Professionals Version (Phase II)
11 item self-report measuring one's experiences as a healthcare professional and how they are feeling currently. Scored between 1-10. Higher scores indicate greater moral distress.
Time frame: Start of Phase II to approximately 5 weeks
Change in score on the Modified Moral Injury Events Scale (Phase I)
11 item self-report measure that measures moral injury. Statements related to distress or feelings of betrayal related to potentially morally injurious events are rated on a 6 point scale ranging from 1 (strongly agree) to 6 (strongly disagree). Score range is 11-66, with higher scores reflecting greater moral injury.
Time frame: Start of Phase I to approximately 2 weeks
Change in score on the Modified Moral Injury Events Scale (Phase II)
11 item self-report measure that measures moral injury. Statements related to distress or feelings of betrayal related to potentially morally injurious events are rated on a 6 point scale ranging from 1 (strongly agree) to 6 (strongly disagree). Score range is 11-66, with higher scores reflecting greater moral injury.
Time frame: Start of Phase II to approximately 5 weeks
Change in score on the PTSD Checklist for DSM-5 (PCL-5) (Phase I)
The well-validated PCL-5 will assess self-reported PTSD symptom severity. Scores range from 0-80. Higher scores indicate greater symptom severity.
Time frame: Start of Phase I to approximately 2 weeks
Change in score on the PTSD Checklist for DSM-5 (PCL-5) (Phase II)
The well-validated PCL-5 will assess self-reported PTSD symptom severity. Scores range from 0-80. Higher scores indicate greater symptom severity.
Time frame: Start of Phase II to approximately 5 weeks
Change in score on the Sheehan Disability Scale (SDS) (Phase I)
10 point visual analog scale to rate the extent to which work/school, social life and home life or family responsibilities are impaired by his or her symptoms. The 3 items can be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired).
Time frame: Start of Phase I to approximately 2 weeks
Change in score on the Sheehan Disability Scale (SDS) (Phase II)
10 point visual analog scale to rate the extent to which work/school, social life and home life or family responsibilities are impaired by his or her symptoms. The 3 items can be summed into a single dimensional measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired).
Time frame: Start of Phase II to approximately 5 weeks
Change in score on the World Health Organization Quality of Life Scale - Brief (Phase I)
The minimum score is 0 and the maximum score is 100. High score shows better result.
Time frame: Start of Phase I to approximately 2 weeks
Change in score on the World Health Organization Quality of Life Scale - Brief (Phase II)
The minimum score is 0 and the maximum score is 100. High score shows better result.
Time frame: Start of Phase II to approximately 5 weeks
Change in score on the Work and Social Adjustment Scale (WSAS) (Phase I)
5 items measuring one's social functioning on items covering ability to work, home management, social leisure activities, private leisure activities, and close relationships. Each item is scored between 0-8. Lower scores are better.
Time frame: Start of Phase I to approximately 2 weeks
Change in score on the Work and Social Adjustment Scale (WSAS) (Phase II)
5 items measuring one's social functioning on items covering ability to work, home management, social leisure activities, private leisure activities, and close relationships. Each item is scored between 0-8. Lower scores are better.
Time frame: Start of Phase II to approximately 5 weeks
Change in Score on the Occupational Stress Inventory Revised (OSI-R) (Phase I)
The scale is comprised of 140 items total. The measure is comprised of 14 different scales and respondents indicate on a 5-point scale the frequency of a stress-related event.
Time frame: Start of Phase I to approximately 2 weeks
Change in Score on the Occupational Stress Inventory Revised (OSI-R) (Phase II)
The scale is comprised of 140 items total. The measure is comprised of 14 different scales and respondents indicate on a 5-point scale the frequency of a stress-related event.
Time frame: Start of Phase II to approximately 5 weeks
Change in Score on the Multidimensional Scale of Perceived Social Support (MSPSS) (Phase I)
12-item scale with a seven-point scale (from 1=strongly disagree to 7=strongly agree), resulting in a total score in the range of 12-84. Higher scores indicate higher perceived social support by Friends and Family/Significant Others.
Time frame: Start of Phase I to approximately 2 weeks
Change in Score on the Multidimensional Scale of Perceived Social Support (MSPSS) (Phase II)
12-item scale with a seven-point scale (from 1=strongly disagree to 7=strongly agree), resulting in a total score in the range of 12-84. Higher scores indicate higher perceived social support by Friends and Family/Significant Others.
Time frame: Start of Phase II to approximately 5 weeks
Change in score on the Posttraumatic Cognitions Inventory (Phase I)
33-item self-report measure is designed to assess the degree to which a participant agrees with thoughts and beliefs that have been found to be common for individuals who suffer from PTSD. The measure is rated between 1 (Totally disagree) to 7 (Totally agree). The score range is 33-231. Higher scores indicate greater symptom severity.
Time frame: Start of Phase I to approximately 2 weeks
Change in score on the Posttraumatic Cognitions Inventory (Phase II)
33-item self-report measure is designed to assess the degree to which a participant agrees with thoughts and beliefs that have been found to be common for individuals who suffer from PTSD. The measure is rated between 1 (Totally disagree) to 7 (Totally agree). The score range is 33-231. Higher scores indicate greater symptom severity.
Time frame: Start of Phase II to approximately 5 weeks
Change in score on the Difficulties in Emotion Regulation Scale-18 (DERS-18) (Phase I)
The Difficulties in Emotion Regulation Scale-18 (DERS) is a 18-item self-report measure of six facets of emotion regulation. Items are rated on a scale of 1 ("almost never \[0-10%\]") to 5 ("almost always \[91-100%\]"). Higher scores indicate more difficulty in emotion regulation.
Time frame: Start of Phase I to approximately 2 weeks
Change in score on the Difficulties in Emotion Regulation Scale-18 (Phase II)
The Difficulties in Emotion Regulation Scale-18 (DERS-18) is a 18-item self-report measure of six facets of emotion regulation. Items are rated on a scale of 1 ("almost never \[0-10%\]") to 5 ("almost always \[91-100%\]"). Higher scores indicate more difficulty in emotion regulation.
Time frame: Start of Phase II to approximately 5 weeks
Change in score on the Pittsburgh Insomnia Rating Scale-20 Item Version (PIRS_20)
The Pittsburgh Insomnia Rating Scale is a 20 item self report measure. Items are rated on a scale from 0-3. Higher scores indicate higher insomnia severity.
Time frame: Start of Phase I to approximately 2 weeks
Change in score on the Pittsburgh Insomnia Rating Scale-20 Item Version (PIRS_20)
The Pittsburgh Insomnia Rating Scale is a 20 item self report measure. Items are rated on a scale from 0-3. Higher scores indicate higher insomnia severity.
Time frame: Start of Phase II to approximately 5 weeks
Plan to share: No
Started Jan 2022 (actual). Primary completion is estimated for Jan 2028, 72 months after the start.
Of 1,066 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 72 months is above that.
Counting every sponsor, half of 1,094 studies reached it within 35 months; a quarter within 17 and three quarters within 53.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Stress Disorders, Post-Traumatic →
Weill Medical College of Cornell University →